Neural network: an instrument to study flow and packing properties of pharmaceutical powders

In the present study five brands of microcrystalline cellulose (Ph101, Vivapur, Ph 301, Emcocel and Prosolv), three brands of Crospovidone (XL, XL-10 and INF) and pregelatinized Starch were mixed with 2% w/w of Aerosil 200, Aerosil R972 (two different kinds of colloidal silicon dioxide) or Mg stearate, to obtain 27 distinct mixtures. Flow rate, bulk and tapped density of mixtures were measured and tablets were prepared

Neural network: an instrument to study flow and packing properties of pharmaceutical powders

In the present study five brands of microcrystalline cellulose (Ph101, Vivapur, Ph 301, Emcocel and Prosolv), three brands of Crospovidone (XL, XL-10 and INF) and pregelatinized Starch were mixed with 2% w/w of Aerosil 200, Aerosil R972 (two different kinds of colloidal silicon dioxide) or Mg stearate, to obtain 27 distinct mixtures. Flow rate, bulk and tapped density of mixtures were measured and tablets were prepared

Pharmaceutical nanocrystals: production by wet milling and applications

Nanocrystals are regarded as an important nanoformulation approach exhibiting advantages of increased dissolution and saturation solubility with chemical stability and low toxicity. Nanocrystals are produced in the form of nanosuspensions using top-down (e.g., wet milling or high pressure homogenization) and bottom-up methods (e.g., antisolvent precipitation). Wet milling is a scalable method applicable to drugs with different physicochemical and mechanical properties. Nanocrystalline-based formulations, either as liquid nanosuspensions or after downstream processing to solid dosage forms, have been developed as drug delivery systems for various routes of administration (i.e., oral, parenteral, pulmonary, ocular, and dermal). In this review, we summarize and discuss the features, preparation methods, and therapeutic applications of pharmaceutical nanocrystals, highlighting their universality as a formulation approach for poorly soluble drugs

Powder Compaction: Compression Properties of Cellulose Ethers

Effective development of matrix tablets requires a comprehensive understanding of different raw material attributes and their impact on process parameters. Cellulose ethers (CE) are the most commonly used pharmaceutical excipients in the fabrication of hydrophilic matrices. The innate good compression and binding properties of CE enable matrices to be prepared using economical direct compression (DC) techniques. However, DC is sensitive to raw material attributes, thus, impacting the compaction process. This article critically reviews prior knowledge on the mechanism of powder compaction and the compression properties of cellulose ethers, giving timely insight into new developments in this field